Insights from the AUSTRI study on reliever use before and after asthma exacerbations

William Busse; David Stempel; Bhumika Aggarwal; Isabelle Boucot; Richard Forth; Ibrahim Raphiou; Klaus F. Rabe; Helen K. Reddel

doi:10.1016/j.jaip.2022.03.029

Insights from the AUSTRI study on reliever use before and after asthma exacerbations

William Busse, David Stempel, Bhumika Aggarwal^*, Isabelle Boucot, Richard Forth, Ibrahim Raphiou, Klaus F. Rabe, Helen K. Reddel

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

35 Downloads (Pure)

Abstract

Clinical Implications: In clinical practice, attention to high or rising reliever use may help prevent exacerbations, by prompting patients to implement their action plan and reminding them to take their regular controller therapy. If reliever data were available in real-time, they could alert the patient and/or clinician to an impending exacerbation, and could identify patients with ongoing high reliever use, who may be at greater risk of exacerbation.

Original language	English
Pages (from-to)	1916-1918.e2
Number of pages	5
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	10
Issue number	7
DOIs	https://doi.org/10.1016/j.jaip.2022.03.029
Publication status	Published - Jul 2022
Externally published	Yes

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Access to Document

10.1016/j.jaip.2022.03.029Licence: CC BY

Publisher version (open access)Final published version, 373 KBLicence: CC BY

Cite this

@article{589e648b3e754628b020daa679efd3a6,

title = "Insights from the AUSTRI study on reliever use before and after asthma exacerbations",

abstract = "Clinical Implications: In clinical practice, attention to high or rising reliever use may help prevent exacerbations, by prompting patients to implement their action plan and reminding them to take their regular controller therapy. If reliever data were available in real-time, they could alert the patient and/or clinician to an impending exacerbation, and could identify patients with ongoing high reliever use, who may be at greater risk of exacerbation.",

author = "William Busse and David Stempel and Bhumika Aggarwal and Isabelle Boucot and Richard Forth and Ibrahim Raphiou and Rabe, \{Klaus F.\} and Reddel, \{Helen K.\}",

note = "Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2022",

month = jul,

doi = "10.1016/j.jaip.2022.03.029",

language = "English",

volume = "10",

pages = "1916--1918.e2",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "7",

}

TY - JOUR

T1 - Insights from the AUSTRI study on reliever use before and after asthma exacerbations

AU - Busse, William

AU - Stempel, David

AU - Aggarwal, Bhumika

AU - Boucot, Isabelle

AU - Forth, Richard

AU - Raphiou, Ibrahim

AU - Rabe, Klaus F.

AU - Reddel, Helen K.

N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2022/7

Y1 - 2022/7

N2 - Clinical Implications: In clinical practice, attention to high or rising reliever use may help prevent exacerbations, by prompting patients to implement their action plan and reminding them to take their regular controller therapy. If reliever data were available in real-time, they could alert the patient and/or clinician to an impending exacerbation, and could identify patients with ongoing high reliever use, who may be at greater risk of exacerbation.

AB - Clinical Implications: In clinical practice, attention to high or rising reliever use may help prevent exacerbations, by prompting patients to implement their action plan and reminding them to take their regular controller therapy. If reliever data were available in real-time, they could alert the patient and/or clinician to an impending exacerbation, and could identify patients with ongoing high reliever use, who may be at greater risk of exacerbation.

UR - https://www.scopus.com/pages/publications/85129559377

U2 - 10.1016/j.jaip.2022.03.029

DO - 10.1016/j.jaip.2022.03.029

M3 - Article

C2 - 35413473

AN - SCOPUS:85129559377

SN - 2213-2198

VL - 10

SP - 1916-1918.e2

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 7

ER -

Insights from the AUSTRI study on reliever use before and after asthma exacerbations

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this